Hims & Hers Health (HIMS) Other Working Capital Changes (2020 - 2026)
Hims & Hers Health (HIMS) reported Other Working Capital Changes of $38.0 million for Q1 2026, up 3313.2% on a YoY basis from $1.1 million in Q1 2025, and up 184.42% sequentially from -$45.0 million in Q4 2025.
Hims & Hers Health (HIMS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Other Working Capital Changes data on file, last reported at $38.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 3313.2% year-over-year to $38.0 million; the trailing twelve-month figure through Mar 2026 stood at $37.2 million (up 486.92% YoY), and the FY2025 full-year result was -$1.9 million, up 21.69% from the prior year.
- Other Working Capital Changes advanced to $38.0 million in Q1 2026, from -$45.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $21.7 million in Q2 2025 to a low of -$5.3 million in Q2 2024.
- A 5-year average of $4.3 million and a median of $2.7 million in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 7326.57% in 2025, while the deepest fall reached 6497.07% in 2025.
- Tracing HIMS's Other Working Capital Changes over 5 years: stood at -$652000.0 in 2022, then soared by 1275.31% to $7.7 million in 2023, then sank by 108.9% to -$682000.0 in 2024, then sank by 6497.07% to -$45.0 million in 2025, then jumped by 184.42% to $38.0 million in 2026.
- Business Quant data shows HIMS's Other Working Capital Changes at $38.0 million in Q1 2026, -$45.0 million in Q4 2025, and $44.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -645,000.00 |
| Mar 31, 2026 | -645,000.00 |
| Mar 31, 2026 | -645,000.00 |
| Dec 31, 2025 | -2.53 Mn |
| Dec 31, 2025 | -2.53 Mn |
| Dec 31, 2025 | -2.53 Mn |
| Sep 30, 2025 | 16.30 Mn |
| Sep 30, 2025 | 16.30 Mn |
| Sep 30, 2025 | 16.30 Mn |
| Jun 30, 2025 | 21.71 Mn |
| Jun 30, 2025 | 21.71 Mn |
| Jun 30, 2025 | 21.71 Mn |
| Mar 31, 2025 | 16.38 Mn |
| Mar 31, 2025 | 16.38 Mn |
| Mar 31, 2025 | 16.38 Mn |
| Dec 31, 2024 | 7.96 Mn |
| Dec 31, 2024 | 7.96 Mn |
| Dec 31, 2024 | 7.96 Mn |
| Sep 30, 2024 | 105,000.00 |
| Sep 30, 2024 | 105,000.00 |